MACROGENICS, INC. Treasury Stock, Number of Shares Held (Deprecated 2016-01-31)
MACROGENICS, INC. (MGNX) had Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) of 0 shares as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes
us-gaap:TreasuryStockNumberOfSharesHeld · last filed 2016-02-29
- 2015-12-31: Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) 0.00 shares.
- 2015-09-30: Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) 0.00 shares.
- 2015-06-30: Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) 0.00 shares.
- 2015-03-31: Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) 865.00 shares.
| Period end | Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) |
|---|---|
| 2015-12-31 | 0.00 shares 10-K · filed 2016-02-29 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-04 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-05 |
| 2015-03-31 | 865.00 shares 10-Q · filed 2015-05-06 |
| 2014-12-31 | 865.00 shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-05 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-06 |
| 2013-12-31 | 14.38K shares 10-K · filed 2015-03-03 |
| 2013-09-30 | 14.38K shares 10-Q · filed 2013-11-12 |
| 2012-12-31 | 14.38K shares 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |